Company Search:
Advanced Search
Sponsored Links
BARD1 Life Sciences Ltd Company Snapshot
BARD1 Life Sciences Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BARD1 Life Sciences Ltd with three other companies in this sector in AUSTRALIA : Suda Pharmaceuticals Ltd (2021 sales of 263,889.00 Australian Dollars [US$191,778.69 ] ), Living Cell Technologies Ltd (268,184.00 Australian Dollars [US$194,900.04 ] of which 100% was Research and Development), and Immutep Ltd (418,168.00 Australian Dollars [US$303,899.41 ] of which 75% was Cancer Immunotherapy).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BARD1 Life Sciences Ltd
  Stock Performance Chart for BARD1 Life Sciences Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 1.33
(Figures in Australian Dollars)
1 Week -3.6%   13 Weeks -4.3%  
4 Weeks -30.1%   52 Weeks 57.7%  
BARD1 Life Sciences Ltd Key Data:
  Ticker: BD1 Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 510,978
(Year Ending Jan 2022).
Employees: 85
  Currency: Australian Dollars Market Cap: 106,075,147
  Fiscal Yr Ends: June Shares Outstanding: 80,056,715
  Share Type: Ordinary Closely Held Shares: 19,650,424
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.